Related Experiment Video

Updated: Jul 3, 2026

Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

Local immunodiagnosis of pulmonary TB: ELISPOT or flow cytometry, PPD or ESAT-6?

S Barry, M Lipman, R Breen

    The European Respiratory Journal
    |August 2, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
    09:54

    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

    Published on: February 16, 2020

    Related Experiment Videos

    Last Updated: Jul 3, 2026

    Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
    06:13

    Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

    Published on: November 23, 2010

    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
    09:54

    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

    Published on: February 16, 2020

    Related Concept Videos

    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

    Articles linked to this work by shared authors, journal, and citation graph.

    Radiotherapy Treatment and Beyond - Mapping Radiotherapy Late Effects Service Provision in England.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Impact of COVID-19 and factors associated with long COVID and COVID-19 vaccine uptake in people with HIV in the United Kingdom: Results from Positive Voices 2022.

    HIV medicine·2025

    A diagnostic certainty score to support improvements in culture confirmation of TB.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

    An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.

    BMC infectious diseases·2021

    The effect of a novel Bayesian penalised likelihood PET reconstruction algorithm on the assessment of malignancy risk in solitary pulmonary nodules according to the British Thoracic Society guidelines.

    European journal of radiology·2019

    Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease.

    Public health·2018

    The regulatory landscape in tuberculosis integrated research platforms.

    The European respiratory journal·2026

    Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis.

    The European respiratory journal·2026

    Single-cell multi-omics show disruption of blood and airway T cells in pulmonary long COVID.

    The European respiratory journal·2026

    Beyond Heritable PAH: Pulmonary Hypertension in Genetic Syndromes.

    The European respiratory journal·2026

    Prognostic implication of malignant pleural metastases in stage M1a non-small cell lung cancer in a real-world Dutch cohort receiving chemotherapy and/or immunotherapy.

    The European respiratory journal·2026

    Epigenetic Priming Sensitizes Metastatic Breast Cancer to Checkpoint Blockade by Rewiring the Tumor-Immune Microenvironment.

    Cancer research·2026

    Associations between endoscopic findings and clinicopathological characteristics in primary gastrointestinal lymphoma: a single-center retrospective study.

    Scandinavian journal of gastroenterology·2026

    A Computed Tomography Radiomics Approach for Assessing the T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma and Its Association With Immunotherapy Response.

    Health care science·2026

    A case report and diagnostic-therapeutic analysis of de novo bilateral papillary thyroid carcinoma complicated with stage I a diffuse large B-cell lymphoma (ABC subtype, double-expressor).

    Frontiers in oncology·2026

    Abundant CD8+ tumor-infiltrating lymphocytes in glioblastoma harbor distinct exhaustion signatures in potentially reactive subsets.

    British journal of cancer·2026

    Targeting IKZF2 with molecular glue degraders for cancer immunotherapy.

    Drug discovery today·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us